Citation Tools

Download PDFPDF
Ocrelizumab appears to reduce relapse and disability in multiple sclerosis but quality of evidence is moderate

Download to a citation manager

Cite this article as:
Filippini G
Ocrelizumab appears to reduce relapse and disability in multiple sclerosis but quality of evidence is moderate